![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of Neural Tube Defects After Exposure to Raltegravir During Pregnancy
|
|
|
Reported by Jules Levin
Presented at the CROI: Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA; March 4-7, 2019.
Hala Shamsuddin1; Casey L. Raudenbush1; Brittany L. Sciba1; Yun-Ping Zhou1; T. Christopher Mast2; Wayne L Greaves3; George J. Hanna3; Ronald Leong1; Walter Straus1
Departments of 1Clinical Safety and Risk Management; 2Pharmacoepidemiology; 3Global Clinical Development (North Wales, PA), Merck & Co., Inc., Kenilworth, NJ, USA
![0306191](../images/030619/030619-8/0306191.gif)
![0306192](../images/030619/030619-8/0306192.gif)
![0306193](../images/030619/030619-8/0306193.gif)
![0306194](../images/030619/030619-8/0306194.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|